Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 5
2009 2
2010 3
2011 4
2012 2
2013 2
2014 4
2015 10
2016 3
2017 8
2018 6
2019 7
2020 6
2021 8
2022 8
2023 5
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Endothelial-to-mesenchymal transition in pulmonary hypertension.
Ranchoux B, Antigny F, Rucker-Martin C, Hautefort A, Péchoux C, Bogaard HJ, Dorfmüller P, Remy S, Lecerf F, Planté S, Chat S, Fadel E, Houssaini A, Anegon I, Adnot S, Simonneau G, Humbert M, Cohen-Kaminsky S, Perros F. Ranchoux B, et al. Among authors: antigny f. Circulation. 2015 Mar 17;131(11):1006-18. doi: 10.1161/CIRCULATIONAHA.114.008750. Epub 2015 Jan 15. Circulation. 2015. PMID: 25593290
Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension.
Masson B, Le Ribeuz H, Sabourin J, Laubry L, Woodhouse E, Foster R, Ruchon Y, Dutheil M, Boët A, Ghigna MR, De Montpreville VT, Mercier O, Beech DJ, Benitah JP, Bailey MA, Humbert M, Montani D, Capuano V, Antigny F. Masson B, et al. Among authors: antigny f. Circ Res. 2022 Oct 14;131(9):e102-e119. doi: 10.1161/CIRCRESAHA.122.321041. Epub 2022 Sep 27. Circ Res. 2022. PMID: 36164973 Free article.
Orai1/STIMs modulators in pulmonary vascular diseases.
Saint-Martin Willer A, Montani D, Capuano V, Antigny F. Saint-Martin Willer A, et al. Among authors: antigny f. Cell Calcium. 2024 Apr 24;121:102892. doi: 10.1016/j.ceca.2024.102892. Online ahead of print. Cell Calcium. 2024. PMID: 38735127 Free article. Review.
Use of β-Blockers in Pulmonary Hypertension.
Perros F, de Man FS, Bogaard HJ, Antigny F, Simonneau G, Bonnet S, Provencher S, Galiè N, Humbert M. Perros F, et al. Among authors: antigny f. Circ Heart Fail. 2017 Apr;10(4):e003703. doi: 10.1161/CIRCHEARTFAILURE.116.003703. Circ Heart Fail. 2017. PMID: 28364092 Review.
Pulmonary hypertension associated with diazoxide: the SUR1 paradox.
Montani D, Antigny F, Jutant EM, Chaumais MC, Le Ribeuz H, Grynblat J, Khouri C, Humbert M. Montani D, et al. Among authors: antigny f. ERJ Open Res. 2023 Nov 13;9(6):00350-2023. doi: 10.1183/23120541.00350-2023. eCollection 2023 Nov. ERJ Open Res. 2023. PMID: 37965230 Free PMC article. Review.
Sex and gender in pulmonary arterial hypertension.
Cheron C, McBride SA, Antigny F, Girerd B, Chouchana M, Chaumais MC, Jaïs X, Bertoletti L, Sitbon O, Weatherald J, Humbert M, Montani D. Cheron C, et al. Among authors: antigny f. Eur Respir Rev. 2021 Nov 8;30(162):200330. doi: 10.1183/16000617.0330-2020. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34750113 Free PMC article. Review.
Potassium channels in pulmonary arterial hypertension.
Boucherat O, Chabot S, Antigny F, Perros F, Provencher S, Bonnet S. Boucherat O, et al. Among authors: antigny f. Eur Respir J. 2015 Oct;46(4):1167-77. doi: 10.1183/13993003.00798-2015. Epub 2015 Sep 4. Eur Respir J. 2015. PMID: 26341985 Free article. Review.
KCNK3: new gene target for pulmonary hypertension?
Girerd B, Perros F, Antigny F, Humbert M, Montani D. Girerd B, et al. Among authors: antigny f. Expert Rev Respir Med. 2014 Aug;8(4):385-7. doi: 10.1586/17476348.2014.909731. Epub 2014 Apr 18. Expert Rev Respir Med. 2014. PMID: 24742047
84 results